No Data
No Data
A Piece Of The Puzzle Missing From Guangdong Transtek Medical Electronics Co., Ltd's (SZSE:300562) 28% Share Price Climb
The medical instrument registration application for the wrist electronic blood pressure monitor applied for by Guangdong Transtek Medical Electronics (300562.SZ) has been accepted.
Guangdong Transtek Medical Electronics (300562.SZ) announced that the company recently received the "Acceptance Certificate" issued by the Guangdong Provincial Drug Administration for the clinical trial application of its new pharmaceutical product.
Guangdong Transtek Medical Electronics: Half-year report for the year 2024.
Guangdong Transtek Medical Electronics: Summary of Half-Year Report in 2024.
Guangdong Transtek Medical Electronics (300562.SZ): Net income for the first half of the year was CNY 34.8497 million, a year-on-year increase of 303.72%.
Guangdong Transtek Medical Electronics (300562.SZ) released its semi-annual report, with a revenue of 0.499 billion yuan, a YoY growth of 29.63%, a net income of 34.8497 million yuan, a YoY growth of 303.72%, a non-GAAP net income of 32.38 million yuan, a YoY growth of 313.83%, and a basic earnings per share of 0.1607 yuan. A cash dividend of 1.3 yuan per 10 shares was distributed to all shareholders. Based on the company's strong manufacturing capabilities of medical-grade intelligent health equipment, digital software research and development technology advantages, as well as high-quality medical industry cooperation partner resources, the company accelerates the promotion of digital health services commercialization.
Guangdong Transtek Medical Electronics (300562.SZ): Has accumulated repurchased 1.10% of shares.
Guangdong Transtek Medical Electronics (300562.SZ) announced that as of July 31, 2024, the company repurchased a total of 2,377,200 shares through a repurchase special securities account with a centralized bidding method, accounting for 1.10% of the company's current total equity (the company's current total equity is 216,901,188 shares). From the first repurchase to July 31, 2024, the highest fill price for the company's repurchased shares was 9.74 yuan/share, the lowest fill price was 6.05 yuan/share, and the total amount paid was 20.5009 million yuan (excluding transaction fees).
No Data